References
European Centre for Disease Prevention and Control, Legionnaires’ disease—Annual Epidemiological Report for 2016. https://ecdc.europa.eu/en/publications-data/legionnaires-disease-annual-epidemiological-report-2016. Accessed 8 Aug 2018.
Burdet C, Lepeule R, Duval X, Caseris M, Rioux C, Lucet JC, Yazdanpanah Y. Quinolones versus macrolides in the treatment of legionellosis: a systematic review and meta-analysis. J Antimicrobial Chemother. 2014;69:2354–60.
Garcia-Vidal C, Sanchez-Rodriguez I, Simonetti AF, et al. Levofloxacin versus azithromycin for treating legionella pneumonia: a propensity score analysis. Clin Microbiol Infect. 2017;23:653–8.
Roger PM, Demonchy E, Risso K, et al. Medical table: a major tool for antimicrobial stewardship policy. Med Mal Infect. 2017;47:311–8.
European Commission. Amending Decision 2002/253/EC laying down case definitions for reporting communicable diseasesto the Community network under Decision No 2119/98/EC of the European Parliament and of the Council. OJ L 159, 18.6.2008, 2008. p. 46–90.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
None.
Rights and permissions
About this article
Cite this article
Scussel, R., Risso, K., Demonchy, E. et al. Macrolides or fluoroquinolones as enteral antibiotic therapy for non-ICU legionellosis. Infection 47, 875–876 (2019). https://doi.org/10.1007/s15010-019-01340-3
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s15010-019-01340-3